Huaren Pharmaceutical Co.,Ltd.’s Net Profit Rose 0.6% in First Half of 2022

Huaren Pharmaceutical Co.,Ltd. (华仁药业股份有限公司) (300110.SZ) reported a net profit of 76 million yuan in the first half of 2022, up 0.6% year-on-year.

Meanwhile, the company posted 722 million yuan in revenue, up 2.7% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 53%.